Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Patients go through multiple levels before reaching their usual dose
All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
treating obesity and curtailing its most devastating long-term effects
Avoid in: Patients with a family history of medullary thyroid cancer or personal history of thyroid tumors
This section will break down these factors to help you make an informed decision
US$ 26.26
US$ 29.05
US$ 23.55
US$ 26.14
